Bayer, EDB to fund S$30m regional disease research
Effort will deepen cancer research and expand into heart and eye diseases
Singapore
PHARMACEUTICAL giant Bayer HealthCare and the Singapore Economic Development Board (EDB) will jointly foster translational and clinical research for diseases prevalent in Asia over the next five years, they announced at a launch ceremony on Wednesday.
EDB will facilitate collaborations between Bayer HealthCare and its partner institutes - including SingHealth Duke-NUS Academic Medical Centre and National University Health System (NUHS) - to increase existing research efforts in cancer treatment, and expand into the research of heart and eye diseases.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
Hamas accepts Gaza truce proposal, Israel urges Rafah evacuation
US to snub Putin inauguration
New York judge threatens Trump with jail for gag order violations
Abu Dhabi’s IHC to buy back up to US$1.4 billion of its shares
Dubai’s financial centre expects ‘busiest year’ as firms rush in
Israel strikes Gaza city of Rafah after evacuation order